Elite releases generic Norco
Hydrocodone and acetaminophen is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Elite, a specialty pharmaceutical company developing niche generic products, has launched hydrocodone bitartrate and acetaminophen tablets, CII) 2.5mg/325mg, 5mg/325mg, 7.5mg/325mg and 10mg/325mg tablets, which is a generic of Norco.
Hydrocodone and acetaminophen is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
[Read more: Elite rolls out generic Tylenol with Codeine]
Hydrocodone and acetaminophen has a market value of roughly $300 million, for the 12 months ending September 2024, per IQVIA.
[Read more: Challenges continue, but generics companies see a bright future with biosimilars]